Product Information

BROMFENAC SODIUM 0.09% EYE DRP is a generic product labeled by Aurobindo Pharma Limited, priced at $15.0851 per ML under NDC 65862078917. Its NADAC has been published 184 times since May 10, 2023.

FDA first approved this application on Mar 18, 2022. Its Orange Book therapeutic-equivalence code is AT2.

BROMFENAC SODIUM 0.09% EYE DRP

Bromfenac
$15.0851per ML

Strength

.9 mg/mL

NDC

65862078917

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

10/21/2026

Active Ingredients

BROMFENAC SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA204813

FDA Approved

3/18/2022

TE Code

AT2

On Market Since

3/18/2022

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for BROMFENAC SODIUM 0.09% EYE DRP has been published 184 times since May 10, 2023, and over the history we have for it it has declined 75.9%. The table below summarizes its recorded NADAC range and movement.

Current price$15.0851 per ML
All-time high$77.1696 (Jul 12, 2023)
All-time low$15.0851 (Oct 21, 2026)
52-week high$20.2795
52-week low$15.0851
Median price$21.6718
Average price$27.1484
Largest weekly change-52.1% (Apr 17, 2024)
Weeks tracked184
Tracking sinceMay 10, 2023

Price History

1W

0.0%

1M

-3.5%

3M

-3.7%

6M

-6.1%

1Y

-31.4%

3Y

-62.9%

5Y

N/A

All

-75.9%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BROMFENAC SODIUM 0.09% EYE DRP?

The current National Average Drug Acquisition Cost (NADAC) for BROMFENAC SODIUM 0.09% EYE DRP, manufactured by Aurobindo Pharma Limited, is $15.0851 per ML (NDC 65862078917), effective Nov 11, 2026.

How has the price of BROMFENAC SODIUM 0.09% EYE DRP changed over time?

Over the history we have for it, the NADAC for BROMFENAC SODIUM 0.09% EYE DRP has declined 75.9%. It has been tracked across 184 weekly CMS publications since May 10, 2023.

What are the highest and lowest recorded NADAC prices for BROMFENAC SODIUM 0.09% EYE DRP?

Since May 10, 2023, the NADAC for BROMFENAC SODIUM 0.09% EYE DRP has ranged from a low of $15.0851 (Oct 21, 2026) to a high of $77.1696 (Jul 12, 2023), with a median of $21.6718 per ML.

Are there cheaper alternatives to BROMFENAC SODIUM 0.09% EYE DRP?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BROMFENAC SODIUM 0.09% EYE DRP in a comparable dosage form, but none are currently priced below it.

Who manufactures BROMFENAC SODIUM 0.09% EYE DRP?

BROMFENAC SODIUM 0.09% EYE DRP (NDC 65862078917) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.